Compass Therapeutics CMPX
NASDAQ CMPX
$0.81 -0.02 (-2.26%)
At close: Oct 21, 2026 · 4:00 PM EDT

Compass Therapeutics (CMPX) Asset Utilization Ratio (2024 - 2025)

Updated

Compass Therapeutics' (CMPX) Asset Utilization Ratio came in at 0.01 for Q2 2025, up 27.6% from 0.01 a year earlier.

Analysis

Compass Therapeutics (CMPX) Asset Utilization Ratio (2024 - 2025) Analysis & Trends

Since Q2 2024, Compass Therapeutics has reported Asset Utilization Ratio for 4 quarters.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Asset Util. (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn 0.62
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn 0.49
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn 0.47
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn 0.52
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn 0.46
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn 0.51
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn 0.40
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn 0.58
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn 0.31
10 Compass Therapeutics 152.17 Mn -653.47 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2025 0.01
Dec 31, 2024 0.01
Sep 30, 2024 0.01
Jun 30, 2024 0.01
API Access

Compass Therapeutics Asset Utilization Ratio API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=asset-utilization-ratio&ticker=CMPX&period=max&api_key=YOUR_API_KEY